A composite T?cell biomarker in pre-treatment blood samples correlates with detection of immune-related adverse events.
A composite T?cell biomarker in pre-treatment blood samples correlates with detection of immune-related adverse events. Cancer Cell. 2022 03 14; 40(3):249-251.